These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37640544)

  • 1. Immunotherapy-Responsive Neuropathic Pain and Allodynia in a Patient With Glycine Receptor Autoantibodies: A Case Report.
    Soleimani B; Board C; Yu T; Tracey I; Irani SR; Foley P
    Neurol Neuroimmunol Neuroinflamm; 2023 Nov; 10(6):. PubMed ID: 37640544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine receptor autoantibodies disrupt inhibitory neurotransmission.
    Crisp SJ; Dixon CL; Jacobson L; Chabrol E; Irani SR; Leite MI; Leschziner G; Slaght SJ; Vincent A; Kullmann DM
    Brain; 2019 Nov; 142(11):3398-3410. PubMed ID: 31591639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice.
    Morita K; Motoyama N; Kitayama T; Morioka N; Kifune K; Dohi T
    J Pharmacol Exp Ther; 2008 Aug; 326(2):633-45. PubMed ID: 18448867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling.
    Cioffi CL
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34200954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Different Dynamic Changes of Nerve Growth Factor in the Dorsal Horn and Dorsal Root Ganglion Leads to Hyperalgesia and Allodynia in Diabetic Neuropathic Pain.
    Gao Z; Feng Y; Ju H
    Pain Physician; 2017 May; 20(4):E551-E561. PubMed ID: 28535564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous analgesic action of the pontospinal noradrenergic system spatially restricts and temporally delays the progression of neuropathic pain following tibial nerve injury.
    Hughes SW; Hickey L; Hulse RP; Lumb BM; Pickering AE
    Pain; 2013 Sep; 154(9):1680-1690. PubMed ID: 23707289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to target glycinergic neurotransmission for the treatment of chronic pain.
    Imlach WL
    Pharmacol Res; 2017 Feb; 116():93-99. PubMed ID: 27988386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kir2.1 Channel Regulation of Glycinergic Transmission Selectively Contributes to Dynamic Mechanical Allodynia in a Mouse Model of Spared Nerve Injury.
    Shi Y; Chen Y; Wang Y
    Neurosci Bull; 2019 Apr; 35(2):301-314. PubMed ID: 30203408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
    Dohi T; Morita K; Kitayama T; Motoyama N; Morioka N
    Pharmacol Ther; 2009 Jul; 123(1):54-79. PubMed ID: 19393690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral, inflammatory and neuropathic pain in glycine receptor alpha 3-deficient mice.
    Rácz I; Schütz B; Abo-Salem OM; Zimmer A
    Neuroreport; 2005 Dec; 16(18):2025-8. PubMed ID: 16317347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: analgesic activity of pregabalin, tramadol and duloxetine.
    Le Cudennec C; Castagné V
    Eur J Pharmacol; 2014 Jul; 735():17-25. PubMed ID: 24726848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel alpha-2-delta-1 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states.
    Boroujerdi A; Zeng J; Sharp K; Kim D; Steward O; Luo DZ
    Pain; 2011 Mar; 152(3):649-655. PubMed ID: 21239111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain.
    Werdehausen R; Mittnacht S; Bee LA; Minett MS; Armbruster A; Bauer I; Wood JN; Hermanns H; Eulenburg V
    Pain; 2015 Sep; 156(9):1647-1659. PubMed ID: 25932687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion--Possible implications for neuropathic pain.
    Schlösser L; Barthel F; Brandenburger T; Neumann E; Bauer I; Eulenburg V; Werdehausen R; Hermanns H
    Neurosci Lett; 2015 Jul; 600():213-9. PubMed ID: 26101830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycine Receptor Autoantibodies Impair Receptor Function and Induce Motor Dysfunction.
    Rauschenberger V; von Wardenburg N; Schaefer N; Ogino K; Hirata H; Lillesaar C; Kluck CJ; Meinck HM; Borrmann M; Weishaupt A; Doppler K; Wickel J; Geis C; Sommer C; Villmann C
    Ann Neurol; 2020 Sep; 88(3):544-561. PubMed ID: 32588476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition Mediated by Glycinergic and GABAergic Receptors on Excitatory Neurons in Mouse Superficial Dorsal Horn Is Location-Specific but Modified by Inflammation.
    Takazawa T; Choudhury P; Tong CK; Conway CM; Scherrer G; Flood PD; Mukai J; MacDermott AB
    J Neurosci; 2017 Mar; 37(9):2336-2348. PubMed ID: 28130358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes-induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain.
    Ved N; Da Vitoria Lobo ME; Bestall SM; L Vidueira C; Beazley-Long N; Ballmer-Hofer K; Hirashima M; Bates DO; Donaldson LF; Hulse RP
    J Physiol; 2018 Aug; 596(16):3675-3693. PubMed ID: 29774557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor alpha3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection.
    Hösl K; Reinold H; Harvey RJ; Müller U; Narumiya S; Zeilhofer HU
    Pain; 2006 Dec; 126(1-3):46-53. PubMed ID: 16846696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
    Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
    Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype.
    McKeon A; Martinez-Hernandez E; Lancaster E; Matsumoto JY; Harvey RJ; McEvoy KM; Pittock SJ; Lennon VA; Dalmau J
    JAMA Neurol; 2013 Jan; 70(1):44-50. PubMed ID: 23090334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.